Asia Pacific Biotech News (APBN) is a monthly print and online magazine published by World Scientific. For 20 years, APBN has been reporting on biotechnology, healthcare, food, agriculture and pharmaceutical news in the Asia Pacific region. It is widely read by pharmaceutical and healthcare professionals, biotech investors, clinicians and researchers in the Asia Pacific and worldwide markets.
Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.
GBI has offices in Shanghai, Beijing, and Washington D.C.
KONGPOSH Publications are one of the leading Pharma Publishers from INDIA.
The Pharma Review® is a bi-monthly article based journal. Contributions received from Eminent pharma personalities from India as well as other countries.
The journal has readership in many countries, provides media support to over 25 Pharma Expos and Conferences worldwide and has a large number of advertisers from India and overseas.
The journal is LISTED in Recommended Journals List of Pharmacy Council of INDIA for their approved Institutions. Abstracted & Indexed in International Pharmaceutical Abstract & Chemical Abstract & Listed Ulrich’s Database-USA, and Listed in Journals approved by UGC-INDIA.
Lingmed Ltd was founded in 2013 in Hong Kong, currently we have offices in Shanghai and Beijing. Lingmed promotes three leading intelligence databases for healthcare professionals in China to make better decisions
Lingmed’s core products are healthcare intelligence databases, it covers global innovative assets & China market intelligence. Lingmed’s Products and Services have been recognized by Fortune 500 multinational pharma and device companies as well as Chinese local big pharmacos
In addition, we provide partnering services to bridge European and Chinese pharmaceuticals with biotech companies, including valuation and market monitoring reports
Pharma China (www.pharmachinaonline.com) is the most trusted English media and business intelligence service covering the Chinese pharmaceutical / biopharmaceutical industry and market.
Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks and consulting firms active in China as well as relevant industry associations and government agencies.
- Pharma China Journal Edition (monthly in PDF and Print)
- Pharma China Web Edition (continuously-updated news, in-depth commentaries and online databases)
- China Pharmaceutical Guide (the most comprehensive and authoritative reference for China’s healthcare sector)
Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.
Technology Networks Group is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas.